Page last updated: 2024-09-05

threonyl-lysyl-proline and bromodeoxyuridine

threonyl-lysyl-proline has been researched along with bromodeoxyuridine in 1 studies

Compound Research Comparison

Studies
(threonyl-lysyl-proline)
Trials
(threonyl-lysyl-proline)
Recent Studies (post-2010)
(threonyl-lysyl-proline)
Studies
(bromodeoxyuridine)
Trials
(bromodeoxyuridine)
Recent Studies (post-2010) (bromodeoxyuridine)
70213,164711,816

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emmetsberger, J; Tsirka, SE1

Other Studies

1 other study(ies) available for threonyl-lysyl-proline and bromodeoxyuridine

ArticleYear
Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury.
    Neurobiology of disease, 2012, Volume: 47, Issue:3

    Topics: Animals; Animals, Newborn; Antigens; Autophagy-Related Proteins; Axons; Bromodeoxyuridine; Calcium-Binding Proteins; Cell Proliferation; Cells, Cultured; Cholera Toxin; Chondroitin Sulfate Proteoglycans; Coculture Techniques; Cytokines; Disease Models, Animal; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Ki-67 Antigen; Lipopolysaccharides; Macrophage Activation; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Microscopy, Electron, Transmission; Myelin Basic Protein; Neuroprotective Agents; Oligodendroglia; Oligopeptides; Peptide Fragments; Proteoglycans; Spinal Cord Injuries; Time Factors

2012